8211 - 8220 of 8571 Results
Title
Year
- Participation and consultation engagement strategies have complementary roles: A case study of patient and public involvement in clinical practice guideline development2019OPENTitle: Participation and consultation engagement strategies have complementary roles: A case study of patient and public involvement in clinical practice guideline developmentJournal Name: Health ExpectationsPublisher: WileyVol: 23Issue #: 2Start Page: 423End Page: 432Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/hex.13018Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hex.13018Citation Count: 22
- From a deep learning model back to the brain—Identifying regional predictors and their relation to aging2020OPENTitle: From a deep learning model back to the brain—Identifying regional predictors and their relation to agingJournal Name: Human Brain MappingPublisher: WileyVol: 41Issue #: 12Start Page: 3235End Page: 3252Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1002/hbm.25011Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.25011Citation Count: 87
- Reply to: Psychophysical olfactory testing in COVID‐19: is smell function really impaired in nearly all patients?2020OPENTitle: Reply to: Psychophysical olfactory testing in COVID‐19: is smell function really impaired in nearly all patients?Journal Name: International Forum of Allergy & RhinologyPublisher: WileyVol: 10Issue #: 8Start Page: 953End Page: 954Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alr.22638Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alr.22638Citation Count: 6
-
OPENTitle: Smell dysfunction: a biomarker for COVID‐19Journal Name: International Forum of Allergy & RhinologyPublisher: WileyVol: 10Issue #: 8Start Page: 944End Page: 950Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alr.22587Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alr.22587Citation Count: 814
- Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID‐19 patients2020OPENTitle: Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID‐19 patientsJournal Name: International Forum of Allergy & RhinologyPublisher: WileyVol: 10Issue #: 10Start Page: 1127End Page: 1135Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alr.22680Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alr.22680Citation Count: 93
-
RESTRICTEDTitle: Use of photoacoustic imaging for monitoring vascular disrupting cancer treatmentsJournal Name: Journal of BiophotonicsPublisher: WileyVol: 16Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/jbio.202000209Citation Count: 21
-
RESTRICTEDTitle: Suicide and Lewy body dementia: Report of a Lewy body dementia association working groupJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 36Issue #: 3Start Page: 373End Page: 382Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/gps.5462Citation Count: 13
- Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers Study2020OPENTitle: Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson’s Disease in the Harvard Biomarkers StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 2Start Page: 505End Page: 510Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-191882Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7416447Citation Count: 39
- Pharmacotherapy Use for Non-Motor Symptoms Among de novo Parkinson’s Disease Parkinson’s Progression Markers Initiative Participants2020OPENTitle: Pharmacotherapy Use for Non-Motor Symptoms Among de novo Parkinson’s Disease Parkinson’s Progression Markers Initiative ParticipantsJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 3Start Page: 1239End Page: 1243Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-201973Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7415719Citation Count: 5
- The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson’s Disease: A Feasibility Study2020OPENTitle: The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson’s Disease: A Feasibility StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 4Start Page: 1515End Page: 1527Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-202188Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8640973Citation Count: 30